Related Experiment Video
Updated: Jun 18, 2026

Non-Invasive Model of Neuropathogenic Escherichia coli Infection in the Neonatal Rat
Published on: October 29, 2014
CTX-M beta-lactamase production and virulence of Escherichia coli K1
Damien Dubois1, Nemani V Prasadarao, Rahul Mittal
1University of Auvergne, Clermont-Ferrand F-63001, France.
Abstract:
We report a patient with neonatal meningitis caused by a CTX-M-1-producing Escherichia coli K1 strain. The influence of CTX-M production on virulence was investigated in cell culture and a newborn mouse model of meningitis. CTX-M production had no influence on virulence but was a major factor in clinical outcome.
Insights
Neonatal meningitis caused by Escherichia coli K1 was studied. CTX-M-1 production did not affect bacterial virulence but significantly impacted patient outcomes.
Area of Science:
- Microbiology
- Infectious Diseases
- Neonatal Health
Background:
- Neonatal meningitis poses a significant threat to infant health.
- Escherichia coli K1 is a common cause of bacterial meningitis in newborns.
- CTX-M-1 is a type of beta-lactamase enzyme conferring antibiotic resistance.
Observation:
- A case of neonatal meningitis was identified, caused by a CTX-M-1-producing Escherichia coli K1 strain.
- The study investigated the role of CTX-M-1 production in bacterial virulence.
- Experiments were conducted using cell cultures and a newborn mouse model of meningitis.
Findings:
- CTX-M-1 production did not influence the virulence of the Escherichia coli K1 strain in vitro or in vivo.
- Despite no change in virulence, CTX-M-1 production was a major determinant of the clinical outcome in the patient.
- This suggests that antibiotic resistance mechanisms can disproportionately affect clinical prognosis.
Implications:
- The findings highlight the complex relationship between antibiotic resistance and bacterial pathogenesis.
- Understanding the impact of resistance genes on clinical outcomes is crucial for effective treatment strategies in neonatal meningitis.
- Further research is warranted to elucidate the mechanisms by which CTX-M-1 production influences clinical outcomes beyond direct virulence.
More Related Videos
09:44Characterization of a Pathogenic Escherichia coli Strain Derived from Oreochromis spp. Farms Using Whole-Genome Sequencing
Published on: December 23, 2022
09:26Identification of Antibacterial Immunity Proteins in Escherichia coli using MALDI-TOF-TOF-MS/MS and Top-Down Proteomic Analysis
Published on: May 23, 2021
Related Concept Videos
Clinical Significance of Antibiotic Resistance
Bacterial Gastroenteritis
Stringent Response in E. coli
Determinants of Bacterial Pathogenicity and Virulence
Mechanism of Antibiotic Resistance in MRSA
Regulation of Bacterial Virulence